These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 2926140
1. Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes. Daemen T, Veninga A, Dijkstra J, Scherphof G. J Immunol; 1989 Apr 01; 142(7):2469-74. PubMed ID: 2926140 [Abstract] [Full Text] [Related]
2. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide. Daemen T, Veninga A, Roerdink FH, Scherphof GL. Cancer Res; 1986 Sep 01; 46(9):4330-5. PubMed ID: 3731091 [Abstract] [Full Text] [Related]
3. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators. Fogler WE, Talmadge JE, Fidler IJ. J Reticuloendothel Soc; 1983 Mar 01; 33(3):165-74. PubMed ID: 6834360 [Abstract] [Full Text] [Related]
4. Conditions controlling tumor cytotoxicity of rat liver macrophages mediated by liposomal muramyl dipeptide. Daemen T, Veninga A, Roerdink FH, Scherphof GL. Biochim Biophys Acta; 1989 Apr 25; 991(1):145-51. PubMed ID: 2713416 [Abstract] [Full Text] [Related]
13. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Fidler IJ, Barnes Z, Fogler WE, Kirsh R, Bugelski P, Poste G. Cancer Res; 1982 Feb 25; 42(2):496-501. PubMed ID: 7055801 [Abstract] [Full Text] [Related]
14. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative. Phillips NC, Moras ML, Chedid L, Lefrancier P, Bernard JM. Cancer Res; 1985 Jan 25; 45(1):128-34. PubMed ID: 3838084 [Abstract] [Full Text] [Related]
15. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages. Sone S, Tachibana K, Shono M, Ogushi F, Tsubura E. J Biol Response Mod; 1984 Jan 25; 3(2):185-94. PubMed ID: 6726281 [Abstract] [Full Text] [Related]
16. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages. Sone S, Fidler IJ. J Immunol; 1980 Dec 25; 125(6):2454-60. PubMed ID: 7430635 [Abstract] [Full Text] [Related]
17. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes. Fidler IJ, Fogler WE, Kleinerman ES, Saiki I. J Immunol; 1985 Dec 25; 135(6):4289-96. PubMed ID: 3934281 [Abstract] [Full Text] [Related]
18. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases. Fidler IJ, Schroit AJ. J Immunol; 1984 Jul 25; 133(1):515-8. PubMed ID: 6373933 [Abstract] [Full Text] [Related]
19. Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e. Todd RF, Alvarez PA, Brott DA, Liu DY. J Immunol; 1985 Dec 25; 135(6):3869-77. PubMed ID: 3934269 [Abstract] [Full Text] [Related]